tirzepatide vs tirzepatide with b12 - 60mg Tirzepatide/B12 Injectable (68mg/8mg) | Celia
Description
These medications have garnered significant attention for their weight loss benefits

If necessary, they will adjust your treatment

Other significant considerations include: Injection site reactions (for subcutaneous formulations) Hypoglycaemia risk (particularly if used alongside other glucose-lowering medications) Pancreatitis (rare but serious) Gallbladder disease (including gallstones and cholecystitis) Dehydration leading to acute kidney injury (particularly with severe gastrointestinal side effects) Diabetic retinopathy complications (particularly noted with semaglutide in diabetes patients) Potential thyroid effects (medullary thyroid carcinoma risk in animal studies, though human relevance remains unclear) A Parkinson's-specific concern is that GLP-1 receptor agonists delay gastric emptying, which may further impair levodopa absorption and potentially worsen motor fluctuations or 'OFF' periods in patients on this medication

Ongoing vomiting increases the risk of dehydration and needs attention
How does the switch from semaglutide to tirzepatide usually work

Mindset Becomes the Key Tool: Recognizing this phase as part of the process keeps people focused
